Mkt Cap$2.30T-1.32%
24h Vol$61.79B
BTC Dom56.7%
ETH Dom9.9%
F&G31Fear
BTC$65,148.00-1.23% ETH$1,881.50-2.67% USDT$0.9992-0.02% BNB$567.00-0.60% USDC$0.9999-0.01% XRP$1.11-2.38% SOL$76.14-2.07% TRX$0.3283-0.06% FIGR_HELOC$1.04+3.22% HYPE$57.45-2.47% DOGE$0.0696-4.48% USDS$0.99990.00% RAIN$0.014-2.10% LEO$9.72+0.31% ZEC$500.85-2.20% WBT$56.74-1.35% BTC$65,148.00-1.23% ETH$1,881.50-2.67% USDT$0.9992-0.02% BNB$567.00-0.60% USDC$0.9999-0.01% XRP$1.11-2.38% SOL$76.14-2.07% TRX$0.3283-0.06% FIGR_HELOC$1.04+3.22% HYPE$57.45-2.47% DOGE$0.0696-4.48% USDS$0.99990.00% RAIN$0.014-2.10% LEO$9.72+0.31% ZEC$500.85-2.20% WBT$56.74-1.35%
News

AstraZeneca

Total Stories
1
Section
AstraZeneca
Earnings Review: AstraZeneca Increases Profit Outlook, Reports 17% EPS Growth
Market Analysis

Earnings Review: AstraZeneca Increases Profit Outlook, Reports 17% EPS Growth

AstraZeneca reported an EPS of $1.73 for Q3 2023 and $5.8 for 9M 2023.

Tim FriesNov 9, 20232 min read